These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33294083)

  • 1. Effect of a Multidimensional Pharmaceutical Care Intervention on Inhalation Technique in Patients with Asthma and COPD.
    Wang W; Xu T; Qin Q; Miao L; Bao J; Chen R
    Can Respir J; 2020; 2020():8572636. PubMed ID: 33294083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of inhaler technique on asthma and COPD control: a multicenter experience.
    Dudvarski Ilic A; Zugic V; Zvezdin B; Kopitovic I; Cekerevac I; Cupurdija V; Perhoc N; Veljkovic V; Barac A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2509-2517. PubMed ID: 27785007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
    Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
    BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD
    Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.
    Lavorini F; Magnan A; Dubus JC; Voshaar T; Corbetta L; Broeders M; Dekhuijzen R; Sanchis J; Viejo JL; Barnes P; Corrigan C; Levy M; Crompton GK
    Respir Med; 2008 Apr; 102(4):593-604. PubMed ID: 18083019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Rodrigues AT; Romano S; Romão M; Figueira D; Bulhosa C; Madeira A; Rocha L; Alves J
    Respir Med; 2021; 185():106507. PubMed ID: 34166959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate inhaler technique, an everlasting problem, is associated with poor disease control - A cross sectional study.
    Padmanabhan M; Tamilarasu K; Rajaram M; Batmanabane G
    Adv Respir Med; 2019; 87(4):217-225. PubMed ID: 31476009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD.
    Plaza V; Giner J; Curto E; Alonso-Ortiz MB; Orue MI; Vega JM; Cosío BG;
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):645-653. PubMed ID: 31586668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment according to Montreal Cognitive Assessment independently predicts the ability of chronic obstructive pulmonary disease patients to maintain proper inhaler technique.
    Iamthanaporn C; Wisitsartkul A; Chuaychoo B
    BMC Pulm Med; 2023 Apr; 23(1):144. PubMed ID: 37101175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhalers - between the doctor and the patient.
    Emeryk A; Pirożyński M; Emeryk-Maksymiuk J
    Adv Respir Med; 2018; 86(1):44-52. PubMed ID: 29490421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review.
    Klijn SL; Hiligsmann M; Evers SMAA; Román-Rodríguez M; van der Molen T; van Boven JFM
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):24. PubMed ID: 28408742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' training to improve inhaler technique of patients with COPD in Vietnam.
    Nguyen TS; Nguyen TLH; Van Pham TT; Hua S; Ngo QC; Li SC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1863-1872. PubMed ID: 29928117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of inhaler techniques in patients with asthma and chronic obstructive disease].
    Loukil M; Mejri I; Khalfallah I; Ghrairi H
    Rev Pneumol Clin; 2018 Sep; 74(4):226-234. PubMed ID: 30031594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.
    Hua JL; Ye XF; Du CL; Xie N; Zhang JQ; Li M; Zhang J
    BMC Pulm Med; 2021 Sep; 21(1):302. PubMed ID: 34560863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mishandling of pMDI and DPI inhalers in asthma and COPD - Repetitive and non-repetitive errors.
    Luczak-Wozniak K; Dabrowska M; Domagala I; Miszczuk M; Lubanski W; Leszczynski A; Krenke R
    Pulm Pharmacol Ther; 2018 Aug; 51():65-72. PubMed ID: 29964174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.